nodes	percent_of_prediction	percent_of_DWPC	metapath
Folic Acid—Methotrexate—psoriasis	0.421	1	CrCtD
Folic Acid—GGH—Methotrexate—psoriasis	0.0705	0.287	CbGbCtD
Folic Acid—Pemetrexed—Methotrexate—psoriasis	0.0556	0.2	CrCrCtD
Folic Acid—Raltitrexed—Methotrexate—psoriasis	0.0556	0.2	CrCrCtD
Folic Acid—Tetrahydrofolic acid—Methotrexate—psoriasis	0.0556	0.2	CrCrCtD
Folic Acid—Pralatrexate—Methotrexate—psoriasis	0.0556	0.2	CrCrCtD
Folic Acid—Leucovorin—Methotrexate—psoriasis	0.0556	0.2	CrCrCtD
Folic Acid—SLC46A1—Methotrexate—psoriasis	0.0405	0.165	CbGbCtD
Folic Acid—ABCC11—Methotrexate—psoriasis	0.0339	0.138	CbGbCtD
Folic Acid—MTHFR—Methotrexate—psoriasis	0.0212	0.0862	CbGbCtD
Folic Acid—ABCC3—Cyclosporine—psoriasis	0.0177	0.0719	CbGbCtD
Folic Acid—ABCG2—Mycophenolate mofetil—psoriasis	0.00957	0.039	CbGbCtD
Folic Acid—ABCC3—Methotrexate—psoriasis	0.00934	0.038	CbGbCtD
Folic Acid—ABCG2—Hydrocortisone—psoriasis	0.00768	0.0313	CbGbCtD
Folic Acid—ABCG2—Cyclosporine—psoriasis	0.00725	0.0295	CbGbCtD
Folic Acid—ABCC4—Methotrexate—psoriasis	0.00714	0.0291	CbGbCtD
Folic Acid—SLC22A6—Cyclosporine—psoriasis	0.00587	0.0239	CbGbCtD
Folic Acid—ABCG2—Dexamethasone—psoriasis	0.00478	0.0195	CbGbCtD
Folic Acid—ABCG2—Methotrexate—psoriasis	0.00384	0.0156	CbGbCtD
Folic Acid—CYP2E1—Dexamethasone—psoriasis	0.00341	0.0139	CbGbCtD
Folic Acid—SLC22A6—Methotrexate—psoriasis	0.00311	0.0127	CbGbCtD
Folic Acid—FOLR2—Folate Metabolism—CAT—psoriasis	0.000972	0.0458	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—CAT—psoriasis	0.000972	0.0458	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—IL4—psoriasis	0.000893	0.0421	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—IL4—psoriasis	0.000893	0.0421	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—CRP—psoriasis	0.000771	0.0364	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—CRP—psoriasis	0.000771	0.0364	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—ICAM1—psoriasis	0.000709	0.0334	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—ICAM1—psoriasis	0.000709	0.0334	CbGpPWpGaD
Folic Acid—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.000686	0.0323	CbGpPWpGaD
Folic Acid—SLC46A1—Iron uptake and transport—CP—psoriasis	0.000615	0.029	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—IFNG—psoriasis	0.00054	0.0254	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—IFNG—psoriasis	0.00054	0.0254	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—NFKB1—psoriasis	0.000449	0.0212	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—NFKB1—psoriasis	0.000449	0.0212	CbGpPWpGaD
Folic Acid—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.000425	0.02	CbGpPWpGaD
Folic Acid—GGH—Fluoropyrimidine Activity—TP53—psoriasis	0.000406	0.0192	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—TNF—psoriasis	0.000349	0.0165	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—TNF—psoriasis	0.000349	0.0165	CbGpPWpGaD
Folic Acid—Erythema—Fluocinonide—psoriasis	0.00033	0.00975	CcSEcCtD
Folic Acid—FOLR3—Folate Metabolism—TP53—psoriasis	0.000308	0.0145	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—TP53—psoriasis	0.000308	0.0145	CbGpPWpGaD
Folic Acid—Rash—Calcipotriol—psoriasis	0.000301	0.0089	CcSEcCtD
Folic Acid—Dermatitis—Calcipotriol—psoriasis	0.000301	0.0089	CcSEcCtD
Folic Acid—ABCC3—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000285	0.0134	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—IL6—psoriasis	0.000282	0.0133	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—IL6—psoriasis	0.000282	0.0133	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Beclomethasone—psoriasis	0.000272	0.00803	CcSEcCtD
Folic Acid—ABCC4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000268	0.0126	CbGpPWpGaD
Folic Acid—Depression—Acitretin—psoriasis	0.000263	0.00779	CcSEcCtD
Folic Acid—Erythema—Methoxsalen—psoriasis	0.00026	0.0077	CcSEcCtD
Folic Acid—SLC46A1—Folate Metabolism—CAT—psoriasis	0.000256	0.0121	CbGpPWpGaD
Folic Acid—Dysgeusia—Methoxsalen—psoriasis	0.000255	0.00754	CcSEcCtD
Folic Acid—Pruritus—Tazarotene—psoriasis	0.000249	0.00737	CcSEcCtD
Folic Acid—Ill-defined disorder—Methoxsalen—psoriasis	0.000241	0.00714	CcSEcCtD
Folic Acid—SLC46A1—Folate Metabolism—IL4—psoriasis	0.000235	0.0111	CbGpPWpGaD
Folic Acid—Malaise—Methoxsalen—psoriasis	0.000235	0.00694	CcSEcCtD
Folic Acid—Erythema—Calcitriol—psoriasis	0.000232	0.00686	CcSEcCtD
Folic Acid—Dysgeusia—Calcitriol—psoriasis	0.000227	0.00672	CcSEcCtD
Folic Acid—Rash—Tazarotene—psoriasis	0.000222	0.00656	CcSEcCtD
Folic Acid—Dermatitis—Tazarotene—psoriasis	0.000222	0.00656	CcSEcCtD
Folic Acid—Discomfort—Methoxsalen—psoriasis	0.000219	0.00648	CcSEcCtD
Folic Acid—Agitation—Calcitriol—psoriasis	0.000213	0.00631	CcSEcCtD
Folic Acid—Pruritus—Clobetasol propionate—psoriasis	0.000211	0.00624	CcSEcCtD
Folic Acid—Erythema—Acitretin—psoriasis	0.000206	0.0061	CcSEcCtD
Folic Acid—Erythema—Fluocinolone Acetonide—psoriasis	0.000206	0.00609	CcSEcCtD
Folic Acid—SLC46A1—Folate Metabolism—CRP—psoriasis	0.000203	0.00959	CbGpPWpGaD
Folic Acid—Dysgeusia—Acitretin—psoriasis	0.000202	0.00598	CcSEcCtD
Folic Acid—Dysgeusia—Fluocinolone Acetonide—psoriasis	0.000202	0.00596	CcSEcCtD
Folic Acid—Convulsion—Calcitriol—psoriasis	0.000201	0.00595	CcSEcCtD
Folic Acid—Abdominal distension—Mycophenolic acid—psoriasis	0.000196	0.0058	CcSEcCtD
Folic Acid—Discomfort—Calcitriol—psoriasis	0.000195	0.00577	CcSEcCtD
Folic Acid—Ill-defined disorder—Acitretin—psoriasis	0.000191	0.00566	CcSEcCtD
Folic Acid—Pruritus—Fluocinonide—psoriasis	0.00019	0.00563	CcSEcCtD
Folic Acid—Anaphylactic shock—Calcitriol—psoriasis	0.000189	0.0056	CcSEcCtD
Folic Acid—Rash—Clobetasol propionate—psoriasis	0.000188	0.00556	CcSEcCtD
Folic Acid—Dermatitis—Clobetasol propionate—psoriasis	0.000188	0.00556	CcSEcCtD
Folic Acid—SLC46A1—Folate Metabolism—ICAM1—psoriasis	0.000187	0.00882	CbGpPWpGaD
Folic Acid—Dyspepsia—Methoxsalen—psoriasis	0.000187	0.00553	CcSEcCtD
Folic Acid—Malaise—Acitretin—psoriasis	0.000186	0.00551	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000183	0.00542	CcSEcCtD
Folic Acid—Anorexia—Calcitriol—psoriasis	0.00018	0.00534	CcSEcCtD
Folic Acid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000176	0.00832	CbGpPWpGaD
Folic Acid—Feeling abnormal—Methoxsalen—psoriasis	0.000175	0.00518	CcSEcCtD
Folic Acid—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000174	0.00821	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—NDUFA5—psoriasis	0.000174	0.00819	CbGpPWpGaD
Folic Acid—Discomfort—Acitretin—psoriasis	0.000174	0.00514	CcSEcCtD
Folic Acid—Rash—Beclomethasone—psoriasis	0.000171	0.00507	CcSEcCtD
Folic Acid—Dermatitis—Beclomethasone—psoriasis	0.000171	0.00506	CcSEcCtD
Folic Acid—Rash—Fluocinonide—psoriasis	0.00017	0.00502	CcSEcCtD
Folic Acid—Dermatitis—Fluocinonide—psoriasis	0.00017	0.00501	CcSEcCtD
Folic Acid—Decreased appetite—Calcitriol—psoriasis	0.000165	0.00487	CcSEcCtD
Folic Acid—ABCG2—Iron uptake and transport—CP—psoriasis	0.000164	0.00775	CbGpPWpGaD
Folic Acid—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000164	0.00772	CbGpPWpGaD
Folic Acid—Erythema—Hydroxyurea—psoriasis	0.000162	0.00479	CcSEcCtD
Folic Acid—Nausea—Beclomethasone—psoriasis	0.000161	0.00477	CcSEcCtD
Folic Acid—Anorexia—Acitretin—psoriasis	0.000161	0.00475	CcSEcCtD
Folic Acid—Abdominal distension—Cyclosporine—psoriasis	0.000159	0.00469	CcSEcCtD
Folic Acid—Bronchospasm—Cyclosporine—psoriasis	0.000155	0.00458	CcSEcCtD
Folic Acid—Abdominal distension—Mycophenolate mofetil—psoriasis	0.000155	0.00458	CcSEcCtD
Folic Acid—MTHFR—Folate Metabolism—CAT—psoriasis	0.000155	0.00729	CbGpPWpGaD
Folic Acid—Irritability—Hydrocortisone—psoriasis	0.000155	0.00457	CcSEcCtD
Folic Acid—MTHFR—Vitamin B12 Metabolism—CRP—psoriasis	0.000151	0.00712	CbGpPWpGaD
Folic Acid—Ill-defined disorder—Hydroxyurea—psoriasis	0.00015	0.00445	CcSEcCtD
Folic Acid—Pruritus—Methoxsalen—psoriasis	0.00015	0.00445	CcSEcCtD
Folic Acid—Dyspepsia—Acitretin—psoriasis	0.000148	0.00439	CcSEcCtD
Folic Acid—SLC25A32—Metabolism—CYP2S1—psoriasis	0.000148	0.00696	CbGpPWpGaD
Folic Acid—MTHFR—Vitamin B12 Metabolism—APOE—psoriasis	0.000148	0.00696	CbGpPWpGaD
Folic Acid—Decreased appetite—Acitretin—psoriasis	0.000146	0.00433	CcSEcCtD
Folic Acid—Malaise—Hydroxyurea—psoriasis	0.000146	0.00432	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Acitretin—psoriasis	0.000145	0.0043	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000145	0.00429	CcSEcCtD
Folic Acid—Abdominal distension—Prednisolone—psoriasis	0.000144	0.00427	CcSEcCtD
Folic Acid—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000143	0.00675	CbGpPWpGaD
Folic Acid—SLC46A1—Folate Metabolism—IFNG—psoriasis	0.000142	0.00671	CbGpPWpGaD
Folic Acid—MTHFR—Folate Metabolism—IL4—psoriasis	0.000142	0.0067	CbGpPWpGaD
Folic Acid—Abdominal distension—Hydrocortisone—psoriasis	0.000141	0.00417	CcSEcCtD
Folic Acid—Convulsion—Hydroxyurea—psoriasis	0.00014	0.00415	CcSEcCtD
Folic Acid—Depression—Cyclosporine—psoriasis	0.00014	0.00414	CcSEcCtD
Folic Acid—Feeling abnormal—Acitretin—psoriasis	0.000139	0.00411	CcSEcCtD
Folic Acid—MTHFR—Vitamin B12 Metabolism—ICAM1—psoriasis	0.000139	0.00654	CbGpPWpGaD
Folic Acid—Depression—Mycophenolate mofetil—psoriasis	0.000137	0.00404	CcSEcCtD
Folic Acid—Discomfort—Hydroxyurea—psoriasis	0.000136	0.00403	CcSEcCtD
Folic Acid—Pruritus—Calcitriol—psoriasis	0.000134	0.00396	CcSEcCtD
Folic Acid—Rash—Methoxsalen—psoriasis	0.000134	0.00396	CcSEcCtD
Folic Acid—Dermatitis—Methoxsalen—psoriasis	0.000134	0.00396	CcSEcCtD
Folic Acid—Flatulence—Mycophenolic acid—psoriasis	0.000134	0.00396	CcSEcCtD
Folic Acid—Abdominal distension—Triamcinolone—psoriasis	0.000133	0.00393	CcSEcCtD
Folic Acid—Irritability—Betamethasone—psoriasis	0.000132	0.00391	CcSEcCtD
Folic Acid—Irritability—Dexamethasone—psoriasis	0.000132	0.00391	CcSEcCtD
Folic Acid—Nausea—Methoxsalen—psoriasis	0.000126	0.00373	CcSEcCtD
Folic Acid—Anorexia—Hydroxyurea—psoriasis	0.000126	0.00373	CcSEcCtD
Folic Acid—Ill-defined disorder—Mycophenolic acid—psoriasis	0.000126	0.00372	CcSEcCtD
Folic Acid—Agitation—Mycophenolic acid—psoriasis	0.000125	0.00369	CcSEcCtD
Folic Acid—MTHFR—Selenium Micronutrient Network—CAT—psoriasis	0.000123	0.00579	CbGpPWpGaD
Folic Acid—MTHFR—Folate Metabolism—CRP—psoriasis	0.000123	0.00579	CbGpPWpGaD
Folic Acid—Malaise—Mycophenolic acid—psoriasis	0.000122	0.00362	CcSEcCtD
Folic Acid—Rash—Calcitriol—psoriasis	0.000119	0.00353	CcSEcCtD
Folic Acid—Dermatitis—Calcitriol—psoriasis	0.000119	0.00353	CcSEcCtD
Folic Acid—Pruritus—Acitretin—psoriasis	0.000119	0.00353	CcSEcCtD
Folic Acid—Pruritus—Fluocinolone Acetonide—psoriasis	0.000119	0.00352	CcSEcCtD
Folic Acid—SLC46A1—Folate Metabolism—NFKB1—psoriasis	0.000118	0.00558	CbGpPWpGaD
Folic Acid—Dyspnoea—Hydroxyurea—psoriasis	0.000118	0.00349	CcSEcCtD
Folic Acid—Convulsion—Mycophenolic acid—psoriasis	0.000118	0.00348	CcSEcCtD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000117	0.0055	CbGpPWpGaD
Folic Acid—Dyspepsia—Hydroxyurea—psoriasis	0.000116	0.00344	CcSEcCtD
Folic Acid—Irritability—Prednisone—psoriasis	0.000115	0.0034	CcSEcCtD
Folic Acid—Decreased appetite—Hydroxyurea—psoriasis	0.000115	0.0034	CcSEcCtD
Folic Acid—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000114	0.00538	CbGpPWpGaD
Folic Acid—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000114	0.00338	CcSEcCtD
Folic Acid—Discomfort—Mycophenolic acid—psoriasis	0.000114	0.00338	CcSEcCtD
Folic Acid—MTHFR—Folate Metabolism—ICAM1—psoriasis	0.000113	0.00532	CbGpPWpGaD
Folic Acid—Nausea—Calcitriol—psoriasis	0.000112	0.00333	CcSEcCtD
Folic Acid—ABCC11—Transmembrane transport of small molecules—CP—psoriasis	0.000112	0.00528	CbGpPWpGaD
Folic Acid—Confusional state—Mycophenolic acid—psoriasis	0.000112	0.0033	CcSEcCtD
Folic Acid—ABCC4—Hemostasis—SERPINB8—psoriasis	0.000111	0.00524	CbGpPWpGaD
Folic Acid—Feeling abnormal—Hydroxyurea—psoriasis	0.000109	0.00322	CcSEcCtD
Folic Acid—Flatulence—Cyclosporine—psoriasis	0.000108	0.0032	CcSEcCtD
Folic Acid—Dysgeusia—Cyclosporine—psoriasis	0.000107	0.00318	CcSEcCtD
Folic Acid—ABCC11—Transmembrane transport of small molecules—CARM1—psoriasis	0.000107	0.00503	CbGpPWpGaD
Folic Acid—Rash—Acitretin—psoriasis	0.000106	0.00314	CcSEcCtD
Folic Acid—Dermatitis—Acitretin—psoriasis	0.000106	0.00314	CcSEcCtD
Folic Acid—Rash—Fluocinolone Acetonide—psoriasis	0.000106	0.00313	CcSEcCtD
Folic Acid—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000106	0.00313	CcSEcCtD
Folic Acid—Anorexia—Mycophenolic acid—psoriasis	0.000106	0.00312	CcSEcCtD
Folic Acid—MTHFR—Vitamin B12 Metabolism—IFNG—psoriasis	0.000106	0.00498	CbGpPWpGaD
Folic Acid—Flatulence—Mycophenolate mofetil—psoriasis	0.000106	0.00312	CcSEcCtD
Folic Acid—Abdominal distension—Prednisone—psoriasis	0.000105	0.0031	CcSEcCtD
Folic Acid—Dysgeusia—Mycophenolate mofetil—psoriasis	0.000105	0.0031	CcSEcCtD
Folic Acid—Ill-defined disorder—Cyclosporine—psoriasis	0.000102	0.00301	CcSEcCtD
Folic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000102	0.0048	CbGpPWpGaD
Folic Acid—Agitation—Cyclosporine—psoriasis	0.000101	0.00298	CcSEcCtD
Folic Acid—Nausea—Acitretin—psoriasis	0.0001	0.00296	CcSEcCtD
Folic Acid—Erythema—Prednisolone—psoriasis	9.99e-05	0.00296	CcSEcCtD
Folic Acid—Nausea—Fluocinolone Acetonide—psoriasis	9.98e-05	0.00295	CcSEcCtD
Folic Acid—Ill-defined disorder—Mycophenolate mofetil—psoriasis	9.94e-05	0.00294	CcSEcCtD
Folic Acid—Malaise—Cyclosporine—psoriasis	9.9e-05	0.00293	CcSEcCtD
Folic Acid—Dyspnoea—Mycophenolic acid—psoriasis	9.87e-05	0.00292	CcSEcCtD
Folic Acid—Agitation—Mycophenolate mofetil—psoriasis	9.84e-05	0.00291	CcSEcCtD
Folic Acid—Erythema—Hydrocortisone—psoriasis	9.76e-05	0.00289	CcSEcCtD
Folic Acid—MTHFR—Selenium Micronutrient Network—CRP—psoriasis	9.75e-05	0.0046	CbGpPWpGaD
Folic Acid—Dyspepsia—Mycophenolic acid—psoriasis	9.75e-05	0.00288	CcSEcCtD
Folic Acid—Malaise—Mycophenolate mofetil—psoriasis	9.66e-05	0.00286	CcSEcCtD
Folic Acid—Decreased appetite—Mycophenolic acid—psoriasis	9.63e-05	0.00285	CcSEcCtD
Folic Acid—Irritability—Methotrexate—psoriasis	9.61e-05	0.00284	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Mycophenolic acid—psoriasis	9.56e-05	0.00283	CcSEcCtD
Folic Acid—Convulsion—Cyclosporine—psoriasis	9.51e-05	0.00281	CcSEcCtD
Folic Acid—Convulsion—Mycophenolate mofetil—psoriasis	9.28e-05	0.00274	CcSEcCtD
Folic Acid—Ill-defined disorder—Prednisolone—psoriasis	9.27e-05	0.00274	CcSEcCtD
Folic Acid—Depression—Prednisone—psoriasis	9.26e-05	0.00274	CcSEcCtD
Folic Acid—Discomfort—Cyclosporine—psoriasis	9.23e-05	0.00273	CcSEcCtD
Folic Acid—SLC46A1—Folate Metabolism—TNF—psoriasis	9.21e-05	0.00434	CbGpPWpGaD
Folic Acid—Erythema—Triamcinolone—psoriasis	9.19e-05	0.00272	CcSEcCtD
Folic Acid—Feeling abnormal—Mycophenolic acid—psoriasis	9.13e-05	0.0027	CcSEcCtD
Folic Acid—Ill-defined disorder—Hydrocortisone—psoriasis	9.05e-05	0.00268	CcSEcCtD
Folic Acid—Confusional state—Cyclosporine—psoriasis	9.03e-05	0.00267	CcSEcCtD
Folic Acid—Malaise—Prednisolone—psoriasis	9.01e-05	0.00266	CcSEcCtD
Folic Acid—Discomfort—Mycophenolate mofetil—psoriasis	9.01e-05	0.00266	CcSEcCtD
Folic Acid—Dysgeusia—Triamcinolone—psoriasis	9e-05	0.00266	CcSEcCtD
Folic Acid—MTHFR—Selenium Micronutrient Network—ICAM1—psoriasis	8.96e-05	0.00423	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Cyclosporine—psoriasis	8.96e-05	0.00265	CcSEcCtD
Folic Acid—Confusional state—Mycophenolate mofetil—psoriasis	8.81e-05	0.00261	CcSEcCtD
Folic Acid—Malaise—Hydrocortisone—psoriasis	8.8e-05	0.0026	CcSEcCtD
Folic Acid—MTHFR—Vitamin B12 Metabolism—NFKB1—psoriasis	8.78e-05	0.00414	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Mycophenolate mofetil—psoriasis	8.74e-05	0.00259	CcSEcCtD
Folic Acid—Convulsion—Prednisolone—psoriasis	8.65e-05	0.00256	CcSEcCtD
Folic Acid—MTHFR—Folate Metabolism—IFNG—psoriasis	8.59e-05	0.00405	CbGpPWpGaD
Folic Acid—ABCC3—NRF2 pathway—TGFA—psoriasis	8.55e-05	0.00403	CbGpPWpGaD
Folic Acid—Anorexia—Cyclosporine—psoriasis	8.54e-05	0.00253	CcSEcCtD
Folic Acid—MTHFR—Fluoropyrimidine Activity—TP53—psoriasis	8.53e-05	0.00402	CbGpPWpGaD
Folic Acid—Ill-defined disorder—Triamcinolone—psoriasis	8.52e-05	0.00252	CcSEcCtD
Folic Acid—Convulsion—Hydrocortisone—psoriasis	8.45e-05	0.0025	CcSEcCtD
Folic Acid—Discomfort—Prednisolone—psoriasis	8.4e-05	0.00249	CcSEcCtD
Folic Acid—Rash—Hydroxyurea—psoriasis	8.34e-05	0.00247	CcSEcCtD
Folic Acid—Erythema—Dexamethasone—psoriasis	8.33e-05	0.00247	CcSEcCtD
Folic Acid—Erythema—Betamethasone—psoriasis	8.33e-05	0.00247	CcSEcCtD
Folic Acid—Anorexia—Mycophenolate mofetil—psoriasis	8.33e-05	0.00246	CcSEcCtD
Folic Acid—Dermatitis—Hydroxyurea—psoriasis	8.33e-05	0.00246	CcSEcCtD
Folic Acid—Malaise—Triamcinolone—psoriasis	8.28e-05	0.00245	CcSEcCtD
Folic Acid—Discomfort—Hydrocortisone—psoriasis	8.21e-05	0.00243	CcSEcCtD
Folic Acid—Anaphylactic shock—Prednisolone—psoriasis	8.15e-05	0.00241	CcSEcCtD
Folic Acid—SLC46A1—Folate Metabolism—TP53—psoriasis	8.12e-05	0.00383	CbGpPWpGaD
Folic Acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.11e-05	0.00382	CbGpPWpGaD
Folic Acid—ABCC4—NRF2 pathway—TGFA—psoriasis	8.04e-05	0.00379	CbGpPWpGaD
Folic Acid—Dyspnoea—Cyclosporine—psoriasis	7.99e-05	0.00236	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—NDUFA5—psoriasis	7.97e-05	0.00376	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Hydrocortisone—psoriasis	7.96e-05	0.00236	CcSEcCtD
Folic Acid—Convulsion—Triamcinolone—psoriasis	7.96e-05	0.00235	CcSEcCtD
Folic Acid—Dyspepsia—Cyclosporine—psoriasis	7.89e-05	0.00233	CcSEcCtD
Folic Acid—Nausea—Hydroxyurea—psoriasis	7.85e-05	0.00232	CcSEcCtD
Folic Acid—Pruritus—Mycophenolic acid—psoriasis	7.83e-05	0.00232	CcSEcCtD
Folic Acid—Dyspnoea—Mycophenolate mofetil—psoriasis	7.79e-05	0.00231	CcSEcCtD
Folic Acid—Decreased appetite—Cyclosporine—psoriasis	7.79e-05	0.0023	CcSEcCtD
Folic Acid—Depression—Methotrexate—psoriasis	7.74e-05	0.00229	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Cyclosporine—psoriasis	7.73e-05	0.00229	CcSEcCtD
Folic Acid—Ill-defined disorder—Betamethasone—psoriasis	7.73e-05	0.00229	CcSEcCtD
Folic Acid—Ill-defined disorder—Dexamethasone—psoriasis	7.73e-05	0.00229	CcSEcCtD
Folic Acid—Discomfort—Triamcinolone—psoriasis	7.73e-05	0.00229	CcSEcCtD
Folic Acid—Dyspepsia—Mycophenolate mofetil—psoriasis	7.69e-05	0.00228	CcSEcCtD
Folic Acid—CYP2E1—Biological oxidations—CYP2S1—psoriasis	7.6e-05	0.00358	CbGpPWpGaD
Folic Acid—Decreased appetite—Mycophenolate mofetil—psoriasis	7.6e-05	0.00225	CcSEcCtD
Folic Acid—Anorexia—Hydrocortisone—psoriasis	7.59e-05	0.00225	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	7.54e-05	0.00223	CcSEcCtD
Folic Acid—Malaise—Dexamethasone—psoriasis	7.52e-05	0.00222	CcSEcCtD
Folic Acid—Malaise—Betamethasone—psoriasis	7.52e-05	0.00222	CcSEcCtD
Folic Acid—Anaphylactic shock—Triamcinolone—psoriasis	7.5e-05	0.00222	CcSEcCtD
Folic Acid—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	7.5e-05	0.00353	CbGpPWpGaD
Folic Acid—SLC46A1—Folate Metabolism—IL6—psoriasis	7.43e-05	0.0035	CbGpPWpGaD
Folic Acid—SLC46A1—Transmembrane transport of small molecules—CP—psoriasis	7.41e-05	0.00349	CbGpPWpGaD
Folic Acid—Feeling abnormal—Cyclosporine—psoriasis	7.38e-05	0.00218	CcSEcCtD
Folic Acid—Erythema—Prednisone—psoriasis	7.26e-05	0.00215	CcSEcCtD
Folic Acid—Convulsion—Dexamethasone—psoriasis	7.22e-05	0.00214	CcSEcCtD
Folic Acid—Convulsion—Betamethasone—psoriasis	7.22e-05	0.00214	CcSEcCtD
Folic Acid—SLC25A32—Metabolism—CARM1—psoriasis	7.21e-05	0.0034	CbGpPWpGaD
Folic Acid—Feeling abnormal—Mycophenolate mofetil—psoriasis	7.2e-05	0.00213	CcSEcCtD
Folic Acid—MTHFR—Folate Metabolism—NFKB1—psoriasis	7.14e-05	0.00337	CbGpPWpGaD
Folic Acid—SLC46A1—Transmembrane transport of small molecules—CARM1—psoriasis	7.07e-05	0.00333	CbGpPWpGaD
Folic Acid—Discomfort—Dexamethasone—psoriasis	7.01e-05	0.00207	CcSEcCtD
Folic Acid—Discomfort—Betamethasone—psoriasis	7.01e-05	0.00207	CcSEcCtD
Folic Acid—Dyspepsia—Hydrocortisone—psoriasis	7.01e-05	0.00207	CcSEcCtD
Folic Acid—Rash—Mycophenolic acid—psoriasis	6.98e-05	0.00207	CcSEcCtD
Folic Acid—Dermatitis—Mycophenolic acid—psoriasis	6.98e-05	0.00206	CcSEcCtD
Folic Acid—Decreased appetite—Hydrocortisone—psoriasis	6.92e-05	0.00205	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.87e-05	0.00203	CcSEcCtD
Folic Acid—MTHFR—Vitamin B12 Metabolism—TNF—psoriasis	6.83e-05	0.00322	CbGpPWpGaD
Folic Acid—MTHFR—Selenium Micronutrient Network—IFNG—psoriasis	6.82e-05	0.00322	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Dexamethasone—psoriasis	6.8e-05	0.00201	CcSEcCtD
Folic Acid—Anaphylactic shock—Betamethasone—psoriasis	6.8e-05	0.00201	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—CYP2S1—psoriasis	6.78e-05	0.0032	CbGpPWpGaD
Folic Acid—Ill-defined disorder—Prednisone—psoriasis	6.73e-05	0.00199	CcSEcCtD
Folic Acid—Feeling abnormal—Prednisolone—psoriasis	6.72e-05	0.00199	CcSEcCtD
Folic Acid—Dyspnoea—Triamcinolone—psoriasis	6.68e-05	0.00198	CcSEcCtD
Folic Acid—Agitation—Prednisone—psoriasis	6.67e-05	0.00197	CcSEcCtD
Folic Acid—Dyspepsia—Triamcinolone—psoriasis	6.6e-05	0.00195	CcSEcCtD
Folic Acid—Nausea—Mycophenolic acid—psoriasis	6.58e-05	0.00195	CcSEcCtD
Folic Acid—Feeling abnormal—Hydrocortisone—psoriasis	6.56e-05	0.00194	CcSEcCtD
Folic Acid—CYP2E1—Tryptophan metabolism—CAT—psoriasis	6.56e-05	0.00309	CbGpPWpGaD
Folic Acid—Malaise—Prednisone—psoriasis	6.55e-05	0.00194	CcSEcCtD
Folic Acid—Anorexia—Betamethasone—psoriasis	6.48e-05	0.00192	CcSEcCtD
Folic Acid—Anorexia—Dexamethasone—psoriasis	6.48e-05	0.00192	CcSEcCtD
Folic Acid—Pruritus—Cyclosporine—psoriasis	6.34e-05	0.00188	CcSEcCtD
Folic Acid—Convulsion—Prednisone—psoriasis	6.29e-05	0.00186	CcSEcCtD
Folic Acid—Pruritus—Mycophenolate mofetil—psoriasis	6.18e-05	0.00183	CcSEcCtD
Folic Acid—Feeling abnormal—Triamcinolone—psoriasis	6.18e-05	0.00183	CcSEcCtD
Folic Acid—Discomfort—Prednisone—psoriasis	6.11e-05	0.00181	CcSEcCtD
Folic Acid—Erythema—Methotrexate—psoriasis	6.07e-05	0.00179	CcSEcCtD
Folic Acid—Dyspepsia—Betamethasone—psoriasis	5.99e-05	0.00177	CcSEcCtD
Folic Acid—Dyspepsia—Dexamethasone—psoriasis	5.99e-05	0.00177	CcSEcCtD
Folic Acid—Dysgeusia—Methotrexate—psoriasis	5.94e-05	0.00176	CcSEcCtD
Folic Acid—Anaphylactic shock—Prednisone—psoriasis	5.92e-05	0.00175	CcSEcCtD
Folic Acid—Decreased appetite—Dexamethasone—psoriasis	5.91e-05	0.00175	CcSEcCtD
Folic Acid—Decreased appetite—Betamethasone—psoriasis	5.91e-05	0.00175	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Dexamethasone—psoriasis	5.87e-05	0.00174	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Betamethasone—psoriasis	5.87e-05	0.00174	CcSEcCtD
Folic Acid—MTHFR—Selenium Micronutrient Network—NFKB1—psoriasis	5.68e-05	0.00268	CbGpPWpGaD
Folic Acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.65e-05	0.00267	CbGpPWpGaD
Folic Acid—Rash—Cyclosporine—psoriasis	5.65e-05	0.00167	CcSEcCtD
Folic Acid—Anorexia—Prednisone—psoriasis	5.65e-05	0.00167	CcSEcCtD
Folic Acid—Dermatitis—Cyclosporine—psoriasis	5.64e-05	0.00167	CcSEcCtD
Folic Acid—Pruritus—Hydrocortisone—psoriasis	5.63e-05	0.00167	CcSEcCtD
Folic Acid—Ill-defined disorder—Methotrexate—psoriasis	5.63e-05	0.00167	CcSEcCtD
Folic Acid—Feeling abnormal—Dexamethasone—psoriasis	5.61e-05	0.00166	CcSEcCtD
Folic Acid—Feeling abnormal—Betamethasone—psoriasis	5.61e-05	0.00166	CcSEcCtD
Folic Acid—MTHFR—Folate Metabolism—TNF—psoriasis	5.56e-05	0.00262	CbGpPWpGaD
Folic Acid—MTHFR—Vitamin B12 Metabolism—IL6—psoriasis	5.51e-05	0.0026	CbGpPWpGaD
Folic Acid—Rash—Mycophenolate mofetil—psoriasis	5.51e-05	0.00163	CcSEcCtD
Folic Acid—Dermatitis—Mycophenolate mofetil—psoriasis	5.51e-05	0.00163	CcSEcCtD
Folic Acid—ABCC3—Fluoropyrimidine Activity—TP53—psoriasis	5.47e-05	0.00258	CbGpPWpGaD
Folic Acid—Malaise—Methotrexate—psoriasis	5.47e-05	0.00162	CcSEcCtD
Folic Acid—Nausea—Cyclosporine—psoriasis	5.32e-05	0.00157	CcSEcCtD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	5.32e-05	0.00251	CbGpPWpGaD
Folic Acid—Pruritus—Triamcinolone—psoriasis	5.3e-05	0.00157	CcSEcCtD
Folic Acid—Convulsion—Methotrexate—psoriasis	5.26e-05	0.00155	CcSEcCtD
Folic Acid—Dyspepsia—Prednisone—psoriasis	5.21e-05	0.00154	CcSEcCtD
Folic Acid—Nausea—Mycophenolate mofetil—psoriasis	5.19e-05	0.00154	CcSEcCtD
Folic Acid—Decreased appetite—Prednisone—psoriasis	5.15e-05	0.00152	CcSEcCtD
Folic Acid—ABCC4—Fluoropyrimidine Activity—TP53—psoriasis	5.15e-05	0.00243	CbGpPWpGaD
Folic Acid—Rash—Prednisolone—psoriasis	5.14e-05	0.00152	CcSEcCtD
Folic Acid—Dermatitis—Prednisolone—psoriasis	5.14e-05	0.00152	CcSEcCtD
Folic Acid—Discomfort—Methotrexate—psoriasis	5.1e-05	0.00151	CcSEcCtD
Folic Acid—Rash—Hydrocortisone—psoriasis	5.02e-05	0.00149	CcSEcCtD
Folic Acid—Dermatitis—Hydrocortisone—psoriasis	5.02e-05	0.00148	CcSEcCtD
Folic Acid—Confusional state—Methotrexate—psoriasis	4.99e-05	0.00148	CcSEcCtD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.95e-05	0.00234	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Methotrexate—psoriasis	4.95e-05	0.00146	CcSEcCtD
Folic Acid—MTHFR—Folate Metabolism—TP53—psoriasis	4.9e-05	0.00231	CbGpPWpGaD
Folic Acid—Feeling abnormal—Prednisone—psoriasis	4.88e-05	0.00144	CcSEcCtD
Folic Acid—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	4.88e-05	0.0023	CbGpPWpGaD
Folic Acid—Nausea—Prednisolone—psoriasis	4.84e-05	0.00143	CcSEcCtD
Folic Acid—Pruritus—Betamethasone—psoriasis	4.81e-05	0.00142	CcSEcCtD
Folic Acid—Pruritus—Dexamethasone—psoriasis	4.81e-05	0.00142	CcSEcCtD
Folic Acid—MTHFR—Metabolism—NDUFA5—psoriasis	4.81e-05	0.00227	CbGpPWpGaD
Folic Acid—Nausea—Hydrocortisone—psoriasis	4.73e-05	0.0014	CcSEcCtD
Folic Acid—Rash—Triamcinolone—psoriasis	4.73e-05	0.0014	CcSEcCtD
Folic Acid—Dermatitis—Triamcinolone—psoriasis	4.72e-05	0.0014	CcSEcCtD
Folic Acid—Anorexia—Methotrexate—psoriasis	4.72e-05	0.0014	CcSEcCtD
Folic Acid—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	4.62e-05	0.00218	CbGpPWpGaD
Folic Acid—MTHFR—Folate Metabolism—IL6—psoriasis	4.48e-05	0.00211	CbGpPWpGaD
Folic Acid—Nausea—Triamcinolone—psoriasis	4.45e-05	0.00132	CcSEcCtD
Folic Acid—SLC25A32—Metabolism—CAT—psoriasis	4.44e-05	0.00209	CbGpPWpGaD
Folic Acid—MTHFR—Selenium Micronutrient Network—TNF—psoriasis	4.41e-05	0.00208	CbGpPWpGaD
Folic Acid—Dyspnoea—Methotrexate—psoriasis	4.41e-05	0.00131	CcSEcCtD
Folic Acid—SLC25A32—Disease—HLA-A—psoriasis	4.41e-05	0.00208	CbGpPWpGaD
Folic Acid—Dyspepsia—Methotrexate—psoriasis	4.36e-05	0.00129	CcSEcCtD
Folic Acid—Decreased appetite—Methotrexate—psoriasis	4.3e-05	0.00127	CcSEcCtD
Folic Acid—Rash—Dexamethasone—psoriasis	4.29e-05	0.00127	CcSEcCtD
Folic Acid—Rash—Betamethasone—psoriasis	4.29e-05	0.00127	CcSEcCtD
Folic Acid—Dermatitis—Betamethasone—psoriasis	4.28e-05	0.00127	CcSEcCtD
Folic Acid—Dermatitis—Dexamethasone—psoriasis	4.28e-05	0.00127	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Methotrexate—psoriasis	4.27e-05	0.00126	CcSEcCtD
Folic Acid—Pruritus—Prednisone—psoriasis	4.19e-05	0.00124	CcSEcCtD
Folic Acid—SLC25A32—Disease—APOE—psoriasis	4.12e-05	0.00194	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CYP2S1—psoriasis	4.09e-05	0.00193	CbGpPWpGaD
Folic Acid—Feeling abnormal—Methotrexate—psoriasis	4.08e-05	0.00121	CcSEcCtD
Folic Acid—Nausea—Dexamethasone—psoriasis	4.04e-05	0.0012	CcSEcCtD
Folic Acid—Nausea—Betamethasone—psoriasis	4.04e-05	0.0012	CcSEcCtD
Folic Acid—SLC25A32—Disease—NOS2—psoriasis	3.83e-05	0.00181	CbGpPWpGaD
Folic Acid—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	3.77e-05	0.00178	CbGpPWpGaD
Folic Acid—Rash—Prednisone—psoriasis	3.74e-05	0.00111	CcSEcCtD
Folic Acid—Dermatitis—Prednisone—psoriasis	3.73e-05	0.0011	CcSEcCtD
Folic Acid—MTHFR—Selenium Micronutrient Network—IL6—psoriasis	3.56e-05	0.00168	CbGpPWpGaD
Folic Acid—Nausea—Prednisone—psoriasis	3.52e-05	0.00104	CcSEcCtD
Folic Acid—Pruritus—Methotrexate—psoriasis	3.5e-05	0.00104	CcSEcCtD
Folic Acid—SLC25A32—Metabolism—APOE—psoriasis	3.45e-05	0.00163	CbGpPWpGaD
Folic Acid—ABCC4—Platelet degranulation—VEGFA—psoriasis	3.35e-05	0.00158	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—CARM1—psoriasis	3.31e-05	0.00156	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	3.28e-05	0.00155	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—ITGAL—psoriasis	3.23e-05	0.00152	CbGpPWpGaD
Folic Acid—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	3.2e-05	0.00151	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—TYK2—psoriasis	3.14e-05	0.00148	CbGpPWpGaD
Folic Acid—Rash—Methotrexate—psoriasis	3.12e-05	0.000924	CcSEcCtD
Folic Acid—Dermatitis—Methotrexate—psoriasis	3.12e-05	0.000923	CcSEcCtD
Folic Acid—ABCC3—Metabolism—NDUFA5—psoriasis	3.09e-05	0.00146	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—PPARG—psoriasis	3e-05	0.00142	CbGpPWpGaD
Folic Acid—Nausea—Methotrexate—psoriasis	2.94e-05	0.00087	CcSEcCtD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.88e-05	0.00136	CbGpPWpGaD
Folic Acid—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	2.87e-05	0.00135	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.87e-05	0.00135	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—CD4—psoriasis	2.84e-05	0.00134	CbGpPWpGaD
Folic Acid—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	2.74e-05	0.00129	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	2.7e-05	0.00127	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CYP2S1—psoriasis	2.63e-05	0.00124	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	2.57e-05	0.00121	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	2.35e-05	0.00111	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	2.24e-05	0.00106	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—STAT3—psoriasis	2.2e-05	0.00104	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NDUFA5—psoriasis	2.13e-05	0.001	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—CAT—psoriasis	2.04e-05	0.00096	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—HLA-A—psoriasis	2.02e-05	0.000954	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CARM1—psoriasis	2e-05	0.000942	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	1.98e-05	0.000933	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—APOE—psoriasis	1.89e-05	0.000891	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	1.89e-05	0.00089	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP2S1—psoriasis	1.81e-05	0.000854	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—NOS2—psoriasis	1.76e-05	0.00083	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—APOE—psoriasis	1.58e-05	0.000746	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—IL6—psoriasis	1.54e-05	0.000724	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NDUFA5—psoriasis	1.53e-05	0.000721	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.49e-05	0.000702	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—TYK2—psoriasis	1.44e-05	0.00068	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PPARG—psoriasis	1.38e-05	0.00065	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.38e-05	0.000649	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—NOS2—psoriasis	1.32e-05	0.000624	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—CD4—psoriasis	1.3e-05	0.000615	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP2S1—psoriasis	1.3e-05	0.000613	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CARM1—psoriasis	1.28e-05	0.000605	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CAT—psoriasis	1.23e-05	0.00058	CbGpPWpGaD
Folic Acid—MTHFR—Disease—HLA-A—psoriasis	1.22e-05	0.000576	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.2e-05	0.000565	CbGpPWpGaD
Folic Acid—MTHFR—Disease—APOE—psoriasis	1.14e-05	0.000538	CbGpPWpGaD
Folic Acid—MTHFR—Disease—NOS2—psoriasis	1.06e-05	0.000501	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—STAT3—psoriasis	1.01e-05	0.000476	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—APOE—psoriasis	9.55e-06	0.00045	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CARM1—psoriasis	8.84e-06	0.000417	CbGpPWpGaD
Folic Acid—MTHFR—Disease—TYK2—psoriasis	8.7e-06	0.00041	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PPARG—psoriasis	8.32e-06	0.000392	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CAT—psoriasis	7.89e-06	0.000372	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CD4—psoriasis	7.87e-06	0.000371	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—VEGFA—psoriasis	7.67e-06	0.000362	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—IL6—psoriasis	7.05e-06	0.000333	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CARM1—psoriasis	6.35e-06	0.000299	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—APOE—psoriasis	6.13e-06	0.000289	CbGpPWpGaD
Folic Acid—MTHFR—Disease—STAT3—psoriasis	6.09e-06	0.000287	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—TP53—psoriasis	5.8e-06	0.000273	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CAT—psoriasis	5.44e-06	0.000256	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PPARG—psoriasis	5.34e-06	0.000252	CbGpPWpGaD
Folic Acid—MTHFR—Disease—IL6—psoriasis	4.26e-06	0.000201	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—APOE—psoriasis	4.23e-06	0.000199	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CAT—psoriasis	3.9e-06	0.000184	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PPARG—psoriasis	3.68e-06	0.000174	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—APOE—psoriasis	3.03e-06	0.000143	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PPARG—psoriasis	2.64e-06	0.000125	CbGpPWpGaD
